Pharma

Latest posts

People-power helped Labour adopt policies to tackle big pharma's grip over health


25 September 2019

The Labour Party announced a range of policies to tackle this broken system in which pharma giants gain while patients lose out. It didn’t happen overnight. It’s taken people-power and resources to get the attention of politicians in Labour and other parties. 

The UK government has blatantly chosen to side with big pharma over patients


28 May 2019

The UK government has recklessly blocked global efforts to tackle big pharma secrecy this week in Geneva. But across the world, people are mobilising to give a strong message that it’s time governments put people over the power of big pharma. 

Why is the UK trying to delete all mentions of high drug prices at the World Health Assembly?


21 May 2019

This week in Geneva a resolution is being voted on which could help make drugs more affordable around the world. 

Latest news

Global Justice Now's reaction to the Queen’s Speech.

Health campaigners have welcomed Jeremy Corbyn’s announcement of a range of policies to tackle the failings in the pharmaceutical sector in his speech to the Labour Party conference this afternoon.

Health campaigners have called for the government to make major changes to the way medicines are researched and developed, after new analysis of the cost of leading cancer drugs to the NHS showed that £458 million was spent in 2017/18 on paying pharmaceutical companies for medicines developed with public funding.

Resources

Resource thumbail

Alternatives to the current pharmaceutical system: Activist pack to lobby your MP

December 2018

This briefing is for Global Justice Now local groups and activists to help you to lobby your MP on alternatives to the current corporate-dominated pharmaceutical system.

Resource thumbail

Taking public control of medicines

November 2018

The pharmaceutical industry makes billions in profits from charging high prices for medicines. Meanwhile, people suffer and die from treatable conditions because they can’t afford extortionate prices. This is a system driven by corporate profit that leaves vital medicines out of reach for millions of people – in the UK and around the world. It’s a system that is economically and socially unsustainable and needs urgent reform.